跳至主要内容
临床试验/NL-OMON30745
NL-OMON30745撤回3 期

Intrathecal methylprednisolone for intractable postherpetic neuralgia. - STIP (STeroids for Intractable Postherpetic neuralgia)

niversitair Medisch Centrum Utrecht0 个研究点目标入组 42 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
撤回
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Adult outpatients with a history of postherpetic neuralgia (PHN) for at least 6 months after onset of the vesicular eruption.
  • -Global pain intensity at least 40 mm on 100 mm visual-analogue scale (VAS) despite conventional therapies.

排除标准

  • -PHN in regions innervated by the trigeminal nerve.
  • -Polyneuropathy or severe other neurologic disease.
  • -Diseases accompanied with an immunocompromised state.
  • -Disorders of coagulation (including use of coumarin anticoagulants).
  • -Contra-indications for spinal anesthesia.
  • -Satisfactory pain relief with conventional treatment(s).

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验